Savior Lifetec Co. Receives US ANDA Approval for Meropenem

 Savior Lifetec Corporation announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Meropenem 1GM/Vial and 500MG/Vial on April 19th 2016. Meropenem is an injectable antibiotic. Meropenem belongs to the subgroup of carbapenem, which are considered agents of “last resort” for many complicated bacterial infections.